These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 8750037

  • 21. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 22. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 23. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER.
    J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
    [Abstract] [Full Text] [Related]

  • 24. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 25. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 26. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 27. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB.
    Biol Psychiatry; 2005 Feb 15; 57(4):336-42. PubMed ID: 15705348
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Feb 15; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G.
    J Psychiatr Res; 2007 Feb 15; 41(3-4):290-4. PubMed ID: 16956623
    [Abstract] [Full Text] [Related]

  • 33. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 34. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar 15; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 35. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test.
    Thompson KN, Berger G, Phillips LJ, Komesaroff P, Purcell R, McGorry PD.
    J Psychiatr Res; 2007 Aug 15; 41(5):446-50. PubMed ID: 16403528
    [Abstract] [Full Text] [Related]

  • 36. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

  • 37. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec 15; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 38. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM, Sekula LK, Rubin RT.
    Biol Psychiatry; 1997 Jul 15; 42(2):85-9. PubMed ID: 9209724
    [Abstract] [Full Text] [Related]

  • 39. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
    Neuropsychobiology; 2007 Jul 15; 55(1):28-35. PubMed ID: 17556850
    [Abstract] [Full Text] [Related]

  • 40. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA, Brunner H, Lauer CJ, Uhr M, Yassouridis A, Holsboer F, Friess E.
    J Psychiatr Res; 2008 Oct 15; 42(12):991-9. PubMed ID: 18226817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.